This newsletter highlights a thought-provoking interview between Patrick Collison and Noahpinion, where they delve into critical topics such as U.S. labor productivity and the implications of humanoid robots on society. Additionally, it covers the economic landscape with recent tariffs imposed by the U.S. on imports from Mexico, Canada, and China, raising concerns over potential price increases and trade tensions. Lastly, the FDA has approved a new non-opioid pain medication, alongside news of the Blue Man Group's final performance in NYC, marking the end of an era in live entertainment.